The development of viral variant Omicron BA.5, which is significantly more contagious than its predecessors and is able to overcome existing immunity in many people, is largely to blame for the global uptick in COVID-19 cases.
In This Article...
Which system of the body is most frequently impacted by COVID-19?
SARS-CoV-2-transmitted COVID-19 is a disease that can result in what medical professionals refer to as a respiratory tract infection. It can impact either your lower respiratory tract or upper respiratory tract (sinuses, nose, and throat) (windpipe and lungs).
How long does COVID-19 have a shelf life?
The main way that SARS-CoV-2 (the virus that causes COVID-19) infects people is by exposure to respiratory fluids that are contaminated with the disease-causing virus. Inhaling very small respiratory droplets and aerosol particles, spraying or splashing respiratory droplets and particles directly onto exposed mucous membranes in the mouth, nose, or eyes, and touching mucous membranes with hands that have been contaminatedeither directly by virus-containing respiratory fluids or indirectly by touching surfaces with virusare the three main ways that exposure occurs.
Exhalation causes people to expel respiratory fluids in the form of droplets in a variety of sizes, such as while speaking, singing, exercising, coughing, or sneezing.
1-9 These droplets spread illness and carry viruses.
- Within seconds to minutes, the biggest raindrops swiftly depart from the atmosphere.
- Small enough to remain suspended in the air for minutes to hours are the tiniest very tiny droplets and aerosol particles that are created when these thin droplets rapidly dry.
There are three main methods (none of which are exclusive) wherein respiratory secretions harboring SARS-CoV-2 can expose people to infection:
- Inhalation of air containing infectious virus-carrying aerosol particles and tiny, thin droplets. Within three to six feet of an infectious source, where the quantity of these extremely small droplets and particles is highest, there is the greatest risk of transmission.
- viral buildup on exposed mucous membranes via droplets and particles conveyed in exhaled breath (i.e., “splashes and sprays, such as being coughed on). Additionally, the proximity to an infectious source, where these inhaled droplets and particles are concentrated, increases the risk of transmission.
- contacting inanimate objects contaminated with virus or with hands contaminated with exhaled respiratory fluids that carry virus.
Most people who contract COVID-19 likely won’t experience symptoms for more than two weeks at most, but could test positive months following infection.
Some COVID-19 patients may have detectable virus for up to three months, but that does not make them contagious, according to the Centers for Disease Control and Prevention.
The PCR tests are more likely to detect the virus after infection when it comes to testing.
Dr. Allison Arwady, commissioner of the Chicago Department of Public Health, stated in March that “PCR tests can stay positive for a long time.”
She continued, “Those PCR tests are incredibly sensitive.” “They can sometimes pick up dead viruses for weeks in your nose, but you can’t reproduce those viruses in a lab. It can be positive even though you can’t spread it.”
The U.S. Food and Drug Administration has not approved tests to determine the duration of infectiousness, according to the CDC, who also state that tests “are best utilized early in the course of illness to identify COVID-19.”
There is no mandatory testing to cease isolation for persons with a COVID infection, however the CDC advises performing a fast antigen test for those who decide to do so.
After COVID-19 infection
After symptomatic COVID-19 infection, “a sizable number of men will have testicular edema or swelling of the epididymis,” claims Dr. Deibert.
According to a recent study on the health of male reproductive systems, 10% to 22% of males with acute COVID-19 infection experience orchitis or epididymo-orchitis. The medical term for testicular enlargement or inflammation is orchitis.
Not the first infection that result in enlarged testicles is COVID-19. According to Dr. Deibert, a variety of illnesses, including the mumps, gonorrhea, chlamydia, and E. coli bacteria, can result in testicular enlargement.
After vaccination
There is no evidence to support the claim that the COVID-19 vaccine causes testicular enlargement, with the exception of unsubstantiated accounts on social media. It’s crucial to treat individual experiences differently from scientific studies. In Omaha or elsewhere, according to Dr. Deibert, there is no evidence to support a connection between swelling testicles and the COVID-19 vaccine.
Find out how long spike proteins remain in the body if you’re interested in how mRNA immunization functions.
Is COVID-19 resurgent in the UK?
Newer strains of the omicron variety are driving an increase in covid infection rates in the UK and most of Europe, raising concerns that another wave could disrupt companies and put additional strain on health systems.
According to a survey released on Friday by the Office for National Statistics, the estimated number of people in England who tested positive for Covid-19 rose to approximately 1.4 million in the week ending June 18 or around 1 in 40 people. Comparatively, 1 in 50 persons were affected the week before. The estimate in Scotland rose to about 1 in 20 adults in the most recent week.
What signs and symptoms do BA.4 and BA.5 of Omicron Subvariants present?
The Omicron subvariant BA.5 became disproportionately prevalent in the United States, according to a report from the Centers for Disease Control and Prevention in July.
According to experts, this subvariant of Omicron does not generally exhibit symptoms that are noticeably different from those of earlier iterations. People who have the BA.5 infection may have headaches, muscle pain, weariness, a runny nose, and sore throat. However, compared to people infected with Delta or other coronavirus types, they are less likely to lose their sense of taste and smell or to feel short of breath, according to Dr. Peter Chin-Hong, an infectious disease expert at the University of California, San Francisco.
According to Cleveland Clinic pulmonary and critical care physician Dr. Joseph Khabbaza, upper respiratory problems commonly affect persons “from the voice cords to the tip of the nose. He claimed that, anecdotally, he has observed more patients who have tested positive for Covid-19 while BA.5 has been spreading, many of whom had acute sinus congestion and excruciating sore throats. Because they were in such much discomfort, several of those patients believed they had strep throat, he claimed.
There is yet no proof that this subvariant of Omicron produces more severe disease than earlier iterations. Hospitalizations are rising as a result of the fact that BA.5 is more contagious, according to Dr. Adam Ratner, director of the division of pediatric infectious diseases at Hassenfeld Children’s Hospital at N.Y.U. Langone.
What signs and symptoms do BA.4 and BA.5 of Omicron have?
Runny nose, sore throat, headache, persistent cough, and exhaustion were the most prevalent symptoms reported last week in the U.K., where BA.4 and BA.5 infections also account for the bulk of recent COVID cases.
According to data from the Zoe COVID Symptom Study, which allows people to self-report symptoms through smartphone apps, less than one-third of those surveyed reported having fevers. The symptoms match those that were reported in the spring when the BA.2 subvariant ruled the nation.
According to Dr. Uch Blackstock, head of Advancing Health Equity and a medical contributor to MSNBC, an upgrade to the COVID vaccines is required to combat Omicron BA.4 and BA.5 subvariants, which are now increasing case counts.
The symptoms of BA.5 have been described, and they are comparable to those of earlier COVID variations, according to the University of California Davis Health: fever, runny nose, coughing, sore throat, headaches, muscle soreness, and exhaustion. In comparison to prior omicron strains, there doesn’t now seem to be any difference in the symptoms seen in BA.4 or BA.5 patients.
How do the heart and lungs react to COVID-19?
The COVID-19 virus, SARS-CoV-2, most frequently attacks the lungs, but it can potentially cause life-threatening heart issues.
lung injury
resulting from the virus stops oxygen from getting to the heart muscle, which in turn destroys the heart tissue and stops it from supplying other tissues with oxygen.
The body also reacts to the infection by inducing inflammation, which is typically a necessary response while battling a virus. However, the inflammation appears to go into overdrive in some COVID-19 patients. Too much inflammation could worsen an already-existing arrhythmia, cause more damage to the heart, or interfere with the electrical signals that allow it to beat normally. These effects could limit the heart’s ability to pump blood.
Multisystem inflammatory syndrome in children (MIS-C), which affects kids and teens, is characterized by a high level of inflammation that can particularly harm the heart.
Heart cells may also be impacted by the virus. The extent to which this contributes to the heart damage reported in COVID-19 patients is still being determined by researchers. Some COVID-19 patients who are very unwell have numerous tiny blood clots throughout their bodies, including in their hearts, which can also be harmful. The formation of the clots may be brought on by excessive inflammation, according to researchers.
How might the COVID-19 virus impact my kidneys?
Do the kidneys suffer with COVID-19? It can. The COVID-19 coronavirus, often known as SARS-CoV-2, can seriously injure other organs, such as the heart and kidneys, in addition to targeting the lungs.
The novel coronavirus and its potential impact on kidney function during the course of the illness and as a patient recovers are discussed by C. John Sperati, M.D., M.H.S., a specialist in kidney health.
Can COVID-19 infect other organs besides the lungs?
There are indications that the SARS-CoV-2 virus can infect cells in various regions of the body, including the digestive system, blood vessels, kidneys, and, as this new study demonstrates, the mouth. It is widely established that the upper airways and lungs are the principal sites of SARS-CoV-2 infection.
Does COVID-19 have an airborne life?
According to experts, COVID-19 is primarily passed from person to person via the virus that causes it. There are numerous ways for this to occur:
- aerosols or droplets. The most typical transmission is this one. Droplets or microscopic particles known as aerosols are released from the nose or mouth of an infected person when they cough, sneeze, or speak, releasing the virus into the air. It can be inhaled into the lungs of anyone within 6 feet of that person.
- transmission on the surface. When you touch surfaces that someone with the virus has coughed or sneezed on is a less common way to contract it. You might touch a contaminated doorknob or countertop before touching your lips, eyes, or nose. For two to three days, the virus can survive on surfaces made of plastic and stainless steel. Clean and sanitize any counters, knobs, and other surfaces that you and your family touch frequently throughout the day to stop it.
- Fecal-oral. Infected people’s excrement may include viral particles, according to studies. However, doctors are unsure if contact with contaminated stools can spread the sickness. That person could spread disease to items and people they come into contact with if they use the restroom without washing their hands first.
- Transmission through air. According to research, the virus can survive in the air for up to three hours. If someone who has it exhales and you take that air in, it may enter your lungs. On how frequently the virus spreads via the airborne route and how much it contributes to the pandemic, experts have differing opinions.
Most frequently, those with symptoms are the ones who spread the infection. However, it is possible to transmit it without exhibiting any symptoms. Some persons who are afflicted but are unaware of it can spread it to others. This spread is said to as asymptomatic. Presymptomatic spread refers to the ability to transmit an infection before any symptoms even appear.
How long will COVID-19 endure in contact with surfaces?
The duration of SARS-CoV-2 survival on various porous and non-porous surfaces has been investigated by numerous researchers 10,11,12,13,14,15. Studies show that viable virus cannot be found on porous surfaces for minutes to hours whereas it can be discovered for days or weeks on non-porous surfaces. Compared to non-porous surfaces, SARS-CoV-2 appears to inactivate more quickly on porous surfaces, which may be due to capillary action and quicker aerosol droplet evaporation 16.
On typical non-porous surfaces like stainless steel, plastic, and glass, data from surface survival tests show that a 99% drop in infectious SARS-CoV-2 and other coronaviruses can be anticipated within 3 days (72 hours) of typical indoor environmental conditions. 10,11,12,13,15. However, real-world parameters such as initial virus amount (for example, viral load in respiratory droplets) and elements that can remove or degrade the virus, such as airflow and shifting environmental conditions, do not always reflect experimental settings on porous and non-porous surfaces. 8,9. Additionally, they do not take into consideration the inefficiencies in the virus’s ability to move from surfaces to hands and from hands to mouth, nose, and eyes. 8,9. Actually, investigations in the lab aim to maximize the recovery of viruses from surfaces (e.g., purposefully swabbing the surface multiple times or soaking the contaminated surface in viral transport medium before swabbing). The risk of fomite transmission when a person with COVID-19 has been in an interior space after 3 days (72 hours), independent of when it was last cleaned 8,9,10,11,12,13,15, when taking into consideration both surface survival data and real-world transmission parameters.